ArticleAlimentary pharmacology & therapeutics2018
Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients.
P Ingiliz et al.PubMed ↗Publisher ↗
No numbers read from the abstract.